0000904454-05-000054.txt : 20120705
0000904454-05-000054.hdr.sgml : 20120704
20050127144039
ACCESSION NUMBER: 0000904454-05-000054
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050127
DATE AS OF CHANGE: 20050127
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-79927
FILM NUMBER: 05553412
BUSINESS ADDRESS:
STREET 1: 43 MOULTON STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02138
BUSINESS PHONE: 6174919700
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: MVM International Life Sciences Fund No 1 L P
CENTRAL INDEX KEY: 0001296587
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 0331
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: 6 HENRIETTA STREET
CITY: LONDON
STATE: X0
ZIP: WC2E8PIU
BUSINESS PHONE: 44-2075577517
MAIL ADDRESS:
STREET 1: 6 HENRIETTA STREET
CITY: LONDON
STATE: X0
ZIP: WC2E8PIU
SC 13G
1
s13g_0126-2005momenta.txt
SCHEDULE 13G
CUSIP No. 60877T 10 1 Page 1 of 9 Pages
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILES PURSUANT
TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )(1)
Momenta Pharmaceuticals, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.0001 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
60877T 10 1
--------------------------------------------------------------------------------
June 25, 2004
--------------------------------------------------------------------------------
Date of Event Which Requires Filing of this Statement
Check the appropriate box to designate the rule pursuant to which this Schedule
is Filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
-----------------------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.
CUSIP No. 60877T 10 1 Page 2 of 9 Pages
--------------------------------------------------------------------------------
1) Name of Reporting Person MVM Limited
I.R.S. Identification
No. of Above Person
(Entities Only)
--------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [X]
if a Member of a Group (b) [ ]
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Citizenship or Place United Kingdom
of Organization
--------------------------------------------------------------------------------
Number of 5) Sole Voting
Shares Beneficially Power -0-
Owned by Each
Reporting Person
With
----------------------------------------
6) Shared Voting
Power 8,656 shares
of Common Stock
----------------------------------------
7) Sole Disposi-
tive Power -0-
----------------------------------------
8) Shared Dis-
positive Power 8,656 shares
of Common Stock
----------------------------------------
9) Aggregate Amount Beneficially 8,656 shares
Owned by Each Reporting person of Common Stock
--------------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
--------------------------------------------------------------------------------
11) Percent of Class
Represented by less than 0.1%
Amount in Row (9)
--------------------------------------------------------------------------------
12) Type of Reporting
Person 00
-2-
CUSIP No. 60877T 10 1 Page 3 of 9 Page
--------------------------------------------------------------------------------
1) Name of Reporting Person MVM International Life
I.R.S. Identification Sciences Fund No. 1, L.P.
No. of Above Person
(Entities Only)
--------------------------------------------------------------------------------
2) Check the Appropriate Box (a) [X]
if a Member of a Group (b) [ ]
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Citizenship or Place United Kingdom
of Organization
--------------------------------------------------------------------------------
Number of 5) Sole Voting
Shares Beneficially Power -0-
Owned by Each
Reporting Person
With
----------------------------------------
6) Shared Voting 2,684,748 shares
Power of Common Stock
----------------------------------------
7) Sole Disposi-
tive Power -0-
----------------------------------------
8) Shared Dis- 2,684,748 shares
positive Power of Common Stock
----------------------------------------
9) Aggregate Amount Beneficially 2,684,748 shares
Owned by Each Reporting person of Common Stock
--------------------------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
--------------------------------------------------------------------------------
11) Percent of Class
Represented by 10.6%
Amount in Row (9)
--------------------------------------------------------------------------------
12) Type of Reporting
Person PN
-3-
CUSIP No. 60877T 10 1 Page 4 of 9 Page
--------------------------------------------------------------------------------
Schedule 13G
------------
Item 1(a) - Name of Issuer: Momenta Pharmaceuticals, Inc.
Item 1(b) - Address of Issuer's Principal Executive Offices:
675 West Kendall Street
Cambridge, MA 02142
Item 2(a) - Name of Person Filing:
MVM Limited ("MVM")
MVM International Life Sciences Fund No. 1, L.P.
("MVM Fund No. 1")
Item 2(b) - Address of Principal Business Office:
6 Henrietta Street
London
WC2E 8 PU
United Kingdom
Item 2(c) - Place of Organization:
United Kingdom
Item 2(d) - Title of Class of Securities:
Common Stock, $.0001 par value
Item 2(e) - CUSIP Number: 60877T 10 0
Item 3 - Statements Filed Pursuant to Rules 13d-1(b) or 13d-2(b):
Not applicable.
-4-
CUSIP No. 60877T 10 1 Page 5 of 9 Page
Item 4 - Ownership.
(a) Amount Beneficially Owned:
MVM: 8,656 shares of Common Stock
MVM Fund No. 1: 2,684,748 shares of Common Stock
(b) Percent of Class:
MVM: less than 0.1%
MVM Fund No. 1: 10.6%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote: -0-
(ii) shared power to vote or to direct the vote:
MVM: 8,656 shares of Common Stock
MVM Fund No. 1: 2,684,748 shares of Common Stock
(iii) sole power to dispose or to direct the disposition of: -0-
(iv) shared power to dispose or to direct the disposition of:
MVM: 8,656 shares of Common Stock
MVM Fund No. 1: 2,684,748 shares of Common Stock
Item 5 - Ownership of Five Percent or Less of a Class:
Not applicable.
Item 6 - Ownership of More than Five Percent on Behalf of Another Person:
Not applicable.
Item 7 - Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Company:
Not applicable.
Item 8 - Identification and Classification of Members of the Group:
See Exhibit 2.
-5-
CUSIP No. 60877T 10 1 Page 6 of 9 Page
Item 9 - Notice of Dissolution of Group:
Not applicable.
Item 10 - Certification:
Not applicable.
-6-
CUSIP No. 60877T 10 1 Page 7 of 9 Page
Signature:
After reasonable inquiry and to the best of their knowledge and
belief, the undersigned certify that the information set forth in this statement
is true, complete and correct.
MVM LIMITED
By /s/ Thomas Casdagli
-----------------------------
Director of Finance
MVM INTERNATIONAL LIFE SCIENCES
FUND NO. 1, L.P.
By /s/ Thomas Casdagli
-----------------------------
Director of Finance
Date: January 26, 2005
-7-
CUSIP No. 60877T 10 1 Page 8 of 9 Page
EXHIBIT 1
AGREEMENT OF
MVM LIMITED
AND
MVM INTERNATIONAL LIFE SCIENCES
FUND NO. 1, L.P.
PURSUANT TO RULE 13d-1(f)
-------------------------
The undersigned hereby agree that the Information Statement on
Schedule 13G to which this Agreement is annexed as Exhibit 1 is filed on behalf
of each of them in accordance with provisions of 13d-1(f) under the Securities
Exchange Act of 1934, as amended.
MVM LIMITED
By /s/ Thomas Casdagli
-----------------------------
Director of Finance
MVM INTERNATIONAL LIFE SCIENCES
FUND NO. 1, L.P.
By /s/ Thomas Casdagli
-----------------------------
Director of Finance
Date: January 26, 2005
-8-
CUSIP No. 60877T 10 1 Page 9 of 9 Page
EXHIBIT 2
Identification and Classification
of Members of the Group
---------------------------------
MVM Limited and MVM International Life Sciences Fund No. 1, L.P. are
filing this statement on Schedule 13G as a group.
MVM Limited is a company organized in the United Kingdom. MVM
International Life Sciences Fund No. 1, L.P. is a United Kingdom limited
partnership. MVM Limited is the discretionary investment manager of MVM
International Life Sciences Fund No. 1, L.P.
-9-